Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Clive Roberts who wrote (5701)	11/22/1998 12:04:00 PM
From: scaram(o)uche	Read Replies (1) of 6136

Clive: >> And ...for the record my wonderful wife is now in A1 health and a few weeks back gave birth to a beautiful baby girl. << Always liked your style, now you've got a great story too. Made my day. There's an important lesson in your story, however, a sad one. The capital market at this time is leading some great therapies to the drain. The divergence between first- and third-tier biotech has gotten so extreme that a Centocor or an Agouron, with their valuable therapies, might not thrive if they had to do it today. We now have 40 biotechs with a market cap north of $400 million, and at least 14 north of $1 billion. In contrast, innovative therapies are left wanting for funding among the third-tier, simply because analysts have not been able to differentiate good science from bad....... lambs have been led to slaughter by the "experts", and, to cover their mistakes, the experts damned the sector. Fortunately, we're beginning to emerge from this period where dogmatic bullsh*t ruled. Baby girl.... I know first hand that there's nothing to top that. Congrats! Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next